Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
20%(1 trials)

Phase Distribution

Ph phase_1
2
20%
Ph not_applicable
3
30%

Phase Distribution

2

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
2(40.0%)
N/ANon-phased studies
3(60.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

71.4%

5 of 7 finished

Non-Completion Rate

28.6%

2 ended early

Currently Active

0

trials recruiting

Total Trials

10

all time

Status Distribution
Completed(5)
Terminated(2)
Other(3)

Detailed Status

Completed5
unknown3
Withdrawn2

Development Timeline

Analytics

Development Status

Total Trials
10
Active
0
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 12 (40.0%)
N/A3 (60.0%)

Trials by Status

completed550%
unknown330%
withdrawn220%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
10